Terry-Ann Burrell
Director of Finance/CFO bij BEAM THERAPEUTICS INC.
Vermogen: 3 M $ op 31-03-2024
Profiel
Momenteel bekleedt Terry-Ann Burrell de functie van Chief Financial Officer & Treasurer van Beam Therapeutics, Inc. Mevrouw Burrell zit ook in de raad van bestuur van Recursion Pharmaceuticals, Inc. In haar vorige carrière bekleedde ze de functie van Managing Director bij JPMorgan Securities LLC. Mevrouw Burrell behaalde een bachelordiploma aan de Harvard University en een MBA aan de Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0.09% | 01-04-2024 | 70 137 ( 0.09% ) | 2 M $ | 31-03-2024 |
| 01-04-2024 | 56 314 ( 0.03% ) | 561 451 $ | 31-03-2024 |
Actieve functies van Terry-Ann Burrell
| Bedrijven | Functie | Begin |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director of Finance/CFO | 01-08-2019 |
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 01-04-2020 |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Director/Board Member | 16-01-2024 |
Eerdere bekende functies van Terry-Ann Burrell
| Bedrijven | Functie | Einde |
|---|---|---|
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01-08-2019 |
Opleiding van Terry-Ann Burrell
| Harvard University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
